Katherine A Zarroli, M.D.
Assistant Professor
Department:
Neurology – Jacksonville
Business Phone:
(904) 383-1022
Business Email:
katherine.zarroli@jax.ufl.edu
About Katherine A Zarroli
Katherine Zarroli, M.D., is a University of Florida assistant professor of neurology and a neurologist at the UF Health Neuroscience Institute specializing in clinical neurophysiology and epilepsy.
Dr. Zarroli received her medical degree from the Jefferson Medical College of Thomas Jefferson University in Philadelphia, Pennsylvania. She completed an internal medicine internship at the University of Pennsylvania in Philadelphia, and residency training in neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. She completed fellowships in neurophysiology and epilepsy at the University of Virginia Medical Center in Charlottesville, Virginia. Dr. Zarroli is board-certified in neurology, clinical neurophysiology and epilepsy.
Additional Positions:
Assistant Professor of Neurology
2019 – Current
·
University of Florida
Teaching Profile
Courses Taught
2021
MDC7800 Neurology Clerkship
Board Certifications
-
Clinical NeurophysiologyAmerican Board of Psychiatry and Neurology
-
NeurologyAmerican Board of Psychiatry and Neurology
Clinical Profile
Specialties
- Neurology
Subspecialties
- Clinical Neurophysiology
- Epilepsy
Areas of Interest
- Epilepsy
Research Profile
Goal of identifying novel treatments of catamenial epilepsy.
Open Researcher and Contributor ID (ORCID)
Areas of Interest
- Medically refractory epilepsy – surgical evaluation, treatment, and outcomes
- Women’s Health
Publications
2023
Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Medicine.
102(42)
[DOI] 10.1097/MD.0000000000035545.
[PMID] 37861536.
2023
Symptomatic idiopathic intracranial hypertension triggered by Ramadan intermittent fasting: a case report.
Nutritional neuroscience.
1-4
[DOI] 10.1080/1028415X.2023.2272090.
[PMID] 37948151.
2022
Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
JAMA neurology.
79(12):1267-1276
[DOI] 10.1001/jamaneurol.2022.3651.
[PMID] 36315135.
2021
Dynamic FDG-PET in localization of focal epilepsy: A pilot study.
Epilepsy & behavior : E&B.
122
[DOI] 10.1016/j.yebeh.2021.108204.
[PMID] 34311181.
2021
Improvement in Symptomatic Gastroparesis With Increased Vagal Nerve Stimulation.
Neurology. Clinical practice.
11(1):e18-e19
[DOI] 10.1212/CPJ.0000000000000775.
[PMID] 33968483.
2021
Prolonged post-ictal atrial fibrillation following seizures.
Epilepsy & behavior reports.
16
[DOI] 10.1016/j.ebr.2021.100481.
[PMID] 34693244.
2020
Exploring the clinical value of electrically induced seizures.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology.
131(9):2279-2280
[DOI] 10.1016/j.clinph.2020.07.002.
[PMID] 32713831.
2018
New onset seizures in a patient with Long QT Syndrome (LQTS2) and a pathogenic carboxyl-terminus frameshift variant of the KCNH2 gene.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
53:253-255
[DOI] 10.1016/j.jocn.2018.04.040.
[PMID] 29739726.
2011
Employment after anterior temporal lobectomy.
Epilepsia.
52(5):925-31
[DOI] 10.1111/j.1528-1167.2011.03098.x.
[PMID] 21561447.
Grants
Feb 2024
ACTIVE
A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy
Role: Principal Investigator
Funding: BIOHAVEN PHARMACEUTICALS
Jun 2022
ACTIVE
SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY
Role: Principal Investigator
Funding: NEUROELECTRICS USA
Nov 2021
ACTIVE
Pilot Study of Add-On Fycompa (peramapanel) Treatment for
Catamenial Epilepsy
Role: Principal Investigator
Funding: CATALYST PHARMACEUTICALS
Aug 2020
– Aug 2025
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial With an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 years of Age With Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Role: Principal Investigator
Funding: DRUGDEV INC
via EISAI CO
Education
Epilepsy Fellowship
2019
·
University of Virginia Medical Center
Neurophysiology Fellowship
2018
·
University of Virginia Medical Center
Neurology Residency
2017
·
Beth Israel Deaconess Medical Center
Doctor of Medicine
2013
·
Thomas Jefferson University
Contact Details
Phones:
- Business:
- (904) 383-1022
Emails:
- Business:
- katherine.zarroli@jax.ufl.edu
Asst Administrative:
Addresses:
- Business Mailing:
-
580 W 8TH ST
JACKSONVILLE FL 32209 - Business Street:
-
580 W 8TH ST
9TH FLOOR, TOWER I
JACKSONVILLE FL 322096533